Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China flag China · Delayed Price · Currency is CNY
71.29
+1.11 (1.58%)
Jun 4, 2025, 2:45 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Vaccine
3.96B
Log In
Log In
Log In
Log In
Upgrade
Vaccine Growth
-53.37%
Log In
Log In
Log In
Log In
Upgrade
Diagnostic
1.81B
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Growth
-37.24%
Log In
Log In
Log In
Log In
Upgrade
Other Business
17.30M
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
-6.56%
Log In
Log In
Log In
Log In
Upgrade
Inter-segment Elimination
-276.35M
Log In
Log In
Log In
Log In
Upgrade
Inter-segment Elimination Growth
31.90%
Log In
Log In
Log In
Log In
Upgrade
Reagent
-
Log In
Log In
Log In
Log In
Upgrade
Reagent Growth
-
Log In
Log In
Log In
Log In
Upgrade
Active Ingredients
-
Log In
Log In
Log In
Log In
Upgrade
Active Ingredients Growth
-
Log In
Log In
Log In
Log In
Upgrade
Agent Product
-
Log In
Log In
Log In
Log In
Upgrade
Agent Product Growth
-
Log In
Log In
Log In
Log In
Upgrade
Technical Service
-
Log In
Log In
Log In
Log In
Upgrade
Technical Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Instruments
-
Log In
Log In
Log In
Log In
Upgrade
Instruments Growth
-
Log In
Log In
Log In
Log In
Upgrade
ELISA Diagnostic Reagents
-
Log In
Log In
Log In
Log In
Upgrade
ELISA Diagnostic Reagents Growth
-
Log In
Log In
Log In
Log In
Upgrade
Chemiluminescence
-
Log In
Log In
Log In
Log In
Upgrade
Chemiluminescence Growth
-
Log In
Log In
Log In
Log In
Upgrade
Agent Bole
-
Log In
Log In
Log In
Log In
Upgrade
Agent Bole Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biochemical Reagents
-
Log In
Log In
Log In
Log In
Upgrade
Biochemical Reagents Growth
-
Log In
Log In
Log In
Log In
Upgrade
Quality Control
-
Log In
Log In
Log In
Log In
Upgrade
Quality Control Growth
-
Log In
Log In
Log In
Log In
Upgrade
Colloidal Gold Rapid Diagnostic Test
-
Log In
Log In
Log In
Log In
Upgrade
Colloidal Gold Rapid Diagnostic Test Growth
-
Log In
Log In
Log In
Log In
Upgrade
Agent Other
-
Log In
Log In
Log In
Log In
Upgrade
Agent Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Instruments
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Instruments Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
China
5.34B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-50.17%
Log In
Log In
Log In
Log In
Upgrade
Overseas
151.44M
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
-66.06%
Log In
Log In
Log In
Log In
Upgrade
Taiwan and Hong Kong Australia
-
Log In
Log In
Log In
Log In
Upgrade